EF
CL icon

Empowered Funds’s Colgate-Palmolive CL Stock Holding History

Empowered Funds’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
147,236
+17,168
+13% +$1.5M 0.07% 308
2026
Q1 		$11.1M Buy
+130,068
New +$11.6M 0.07% 341
2025
Q4 		– Sell
-54,800
Closed -$4.38M – 1176
2025
Q3 		$4.38M Sell
54,800
-30,958
-36% -$2.64M 0.04% 529
2025
Q2 		$7.8M Sell
85,758
-4,231
-5% -$386K 0.09% 284
2025
Q1 		$8.43M Buy
89,989
+26,038
+41% +$2.33M 0.12% 206
2024
Q4 		$5.81M Sell
63,951
-5,651
-8% -$539K 0.09% 337
2024
Q3 		$7.23M Buy
69,602
+12,797
+23% +$1.3M 0.11% 253
2024
Q2 		$5.51M Buy
56,805
+23,723
+72% +$2.19M 0.1% 274
2024
Q1 		$2.98M Buy
33,082
+24,314
+277% +$2.06M 0.05% 469
2023
Q4 		$699K Sell
8,768
-4,139
-32% -$311K 0.02% 904
2023
Q3 		$918K Buy
12,907
+7,136
+124% +$534K 0.03% 696
2023
Q2 		$445K Buy
5,771
+2,118
+58% +$164K 0.02% 853
2023
Q1 		$275K Buy
3,653
+1,098
+43% +$81.6K 0.02% 463
2022
Q4 		$201K Buy
+2,555
New +$192K 0.01% 431

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Empowered Funds's CL Position: Q2 2026 in Review

Empowered Funds increased its Colgate-Palmolive (CL) stake by 13% in Q2 2026, buying an estimated $1.5M and bringing the position to 147,236 shares worth $13.5M. The position accounts for 0.07% of the portfolio, ranked #308.

Empowered Funds first reported a position in CL in Q4 2022 and has held it in 14 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Empowered Funds held 147,236 shares of Colgate-Palmolive worth $13.5M as of Q2 2026.
  • Empowered Funds bought 17,168 Colgate-Palmolive shares in Q2 2026, an estimated $1.5M.
  • Colgate-Palmolive made up 0.07% of Empowered Funds's portfolio in Q2 2026, its #308 holding.
  • Empowered Funds first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.